Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$25.61 - $41.78 $1.26 Million - $2.05 Million
-49,098 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$19.65 - $27.99 $549,924 - $783,328
-27,986 Reduced 36.31%
49,098 $1.14 Million
Q2 2021

Aug 16, 2021

BUY
$17.48 - $25.46 $1.35 Million - $1.96 Million
77,084 New
77,084 $1.75 Million
Q3 2020

Nov 05, 2020

SELL
$11.21 - $13.82 $356,141 - $439,061
-31,770 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$9.8 - $12.77 $311,346 - $405,702
31,770 New
31,770 $362,000
Q3 2019

Nov 04, 2019

SELL
$12.75 - $19.01 $1.98 Million - $2.95 Million
-154,933 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$17.0 - $21.88 $2.63 Million - $3.39 Million
154,933 New
154,933 $2.86 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $284M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.